# PHAXIAM Therapeutics

formed in 2023 from Pherecydes' merger with Erytech, PHAXIAM aimed to build a 35-45-phage GMP bank covering the most critical resistant pathogens by end-2026, with commercial IV and orthopedic-infection programs.…


Source: https://cn.bioecon.ru/companies/phaxiam-therapeutics/
Updated: 2026-08-15

- 国家: France

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 2024 年 7 月完成 €780万增资 | https://live.euronext.com/en/products/equities/company-news/2025-01-31-phaxiam-provides-update-deployment-its-strategy-maximize, https://www.globenewswire.com/news-release/2024/09/25/2953185/0/en/PHAXIAM-Provides-Business-and-Financial-Update-For-the-First-Half-of-2024.html |
| 产能 | 目标到2025年底拥有25种GMP噬菌体，到2026年底拥有35-45种 | https://live.euronext.com/en/products/equities/company-news/2025-01-30-phaxiam-therapeutics-and-technophage-enter-strategic, https://live.euronext.com/en/products/equities/company-news/2025-01-31-phaxiam-provides-update-deployment-its-strategy-maximize, https://www.businesswire.com/news/home/20250130268564/en/PHAXIAM-Provides-An-Update-On-The-Deployment-Of-Its-Strategy-To-Maximize-The-Development-Potential-Of-Phage-Therapy |
| 监管批准 | GLORIA 研究于2024年第四季度获美国 FDA IND 批准 | https://live.euronext.com/en/products/equities/company-news/2025-01-31-phaxiam-provides-update-deployment-its-strategy-maximize, https://www.businesswire.com/news/home/20250130268564/en/PHAXIAM-Provides-An-Update-On-The-Deployment-Of-Its-Strategy-To-Maximize-The-Development-Potential-Of-Phage-Therapy, https://www.globenewswire.com/news-release/2024/09/25/2953185/0/en/PHAXIAM-Provides-Business-and-Financial-Update-For-the-First-Half-of-2024.html |
| 生产基地 | 总部位于法国里昂;与Technophage合作生产 | https://prospeo.io/c/phaxiam-therapeutics |
| 员工人数 | 预计员工人数在32至100人之间 [中等置信度] | https://prospeo.io/c/phaxiam-therapeutics |
| 营收 | 目标是2027年实现2000万欧元营收 | https://live.euronext.com/en/products/equities/company-news/2025-01-31-phaxiam-provides-update-deployment-its-strategy-maximize, https://www.businesswire.com/news/home/20250130268564/en/PHAXIAM-Provides-An-Update-On-The-Deployment-Of-Its-Strategy-To-Maximize-The-Development-Potential-Of-Phage-Therapy |

独立来源: businesswire.com, globenewswire.com, live.euronext.com, prospeo.io

## 技术

- [噬菌体疗法](https://cn.bioecon.ru/technology/bacteriophage-therapy/)